tiprankstipranks
Advertisement
Advertisement
CARsgen Grants 4.27 Million Share Options Under Post-IPO Incentive Scheme
PremiumCompany AnnouncementsCARsgen Grants 4.27 Million Share Options Under Post-IPO Incentive Scheme
3M ago
CARsgen Shares Added to Southbound Stock Connect, Opening Door to Mainland Investors
Premium
Company Announcements
CARsgen Shares Added to Southbound Stock Connect, Opening Door to Mainland Investors
3M ago
CARsgen Narrows 2025 Loss as CAR-T Therapy Sales Grow and Costs Fall
Premium
Company Announcements
CARsgen Narrows 2025 Loss as CAR-T Therapy Sales Grow and Costs Fall
3M ago
CARsgen Therapeutics Presents Promising Results for CT0596 at ASH Congress
PremiumCompany AnnouncementsCARsgen Therapeutics Presents Promising Results for CT0596 at ASH Congress
6M ago
CARsgen Therapeutics Updates Share Repurchase Plan and Sees Increased Stake from Key Shareholder
Premium
Company Announcements
CARsgen Therapeutics Updates Share Repurchase Plan and Sees Increased Stake from Key Shareholder
6M ago
CARsgen Therapeutics Launches Long-Term Study on Gene-Modified T-Cell Therapy
Premium
Company Announcements
CARsgen Therapeutics Launches Long-Term Study on Gene-Modified T-Cell Therapy
7M ago
CARsgen Therapeutics Grants Over 6.7 Million Options to Align Employee Interests
PremiumCompany AnnouncementsCARsgen Therapeutics Grants Over 6.7 Million Options to Align Employee Interests
8M ago
CARsgen Presents Updated Results for Zevor-cel at IMS Meeting
Premium
Company Announcements
CARsgen Presents Updated Results for Zevor-cel at IMS Meeting
8M ago
CARsgen Enhances Governance with New Committee
Premium
Company Announcements
CARsgen Enhances Governance with New Committee
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100